|
Orthologous residues
|
|
WWOX (human): Y33‑p, WWOX (mouse): Y33‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
L929 (fibroblast), U-937 (myeloid)
|
|
Cellular systems studied:
cell lines
|
|
Comments:
phosphorylation of WWOX occurs during its binding with p53
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
UV
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization, molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
p53 (human)
|
|
Induces
|
protein stabilization
|
apoptosis, altered
|
yeast two-hybrid
|
|
|
Comments:
formation of the complex with p53 occurs in the presence of MDM2
|